Tang, M. et al. Pulmonary hypertension, mortality, and cardiovascular disease in CKD and ESRD patients: a systematic review and meta-analysis. Am. J. Kidney Dis. 72, 75–83 (2018).

Article  PubMed  Google Scholar 

Bolignano, D., Pisano, A., Coppolino, G., Tripepi, G. L. & D’Arrigo, G. Pulmonary hypertension predicts adverse outcomes in renal patients: a systematic review and meta-analysis. Ther. Apher. Dial. 23, 369–384 (2019).

Article  PubMed  Google Scholar 

Edmonston, D. L. et al. Pulmonary hypertension subtypes and mortality in CKD. Am. J. Kidney Dis. 75, 713–724 (2020).

Article  PubMed  Google Scholar 

Pabst, S. et al. Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: results of the PEPPER-study. PLoS One 7, e35310 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Navaneethan, S. D. et al. Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin. J. Am. Soc. Nephrol. 9, 855–863 (2014).

Article  PubMed  PubMed Central  Google Scholar 

O’Leary, J. M. et al. Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes. Pulm. Circ. 7, 674–683 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Wolfe, J. D. et al. Pulmonary vascular resistance determines mortality in end-stage renal disease patients with pulmonary hypertension. Clin. Transplant. 32, e13270 (2018).

Article  PubMed  Google Scholar 

Brinza, C. et al. Pulmonary arterial hypertension and adverse outcomes after kidney transplantation: a systematic review and meta-analysis. J. Clin. Med. 11, 1944 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Chakinala, M. M. et al. Impact of declining renal function on outcomes in pulmonary arterial hypertension: a REVEAL registry analysis. J. Heart Lung Transplant. 37, 696–705 (2018).

Article  PubMed  Google Scholar 

Shah, S. J. et al. Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension. Circulation 117, 2475–2483 (2008).

Article  CAS  PubMed  Google Scholar 

Nickel, N. P. et al. Low-grade albuminuria in pulmonary arterial hypertension. Pulm. Circ. 9, 2045894018824564 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Benza, R. L. et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 122, 164–172 (2010).

Article  PubMed  Google Scholar 

Leopold, J. A. et al. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat. Med. 13, 189–197 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cohn, J. N. & Tognoni, G. Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N. Engl. J. Med. 345, 1667–1675 (2001).

Article  CAS  PubMed  Google Scholar 

Velazquez, E. J. et al. Angiotensin-neprilysin inhibition in acute decompensated heart failure. N. Engl. J. Med. 380, 539–548 (2019).

Article  CAS  PubMed  Google Scholar 

Maron, B. A. et al. Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension. Circulation 126, 963–974 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maron, B. A. & Leopold, J. A. The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series). Pulm. Circ. 4, 200–210 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Maron, B. A. et al. Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study. Eur. J. Heart Fail. 15, 277–283 (2013).

Article  CAS  PubMed  Google Scholar 

Zhang, J. et al. Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: results from PADN-CFDA trial. J. Heart Lung Transplant. 42, 1140-1151 (2023).

Article  PubMed  Google Scholar 

Calvier, L. et al. Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension. Heart 102, 390–396 (2016).

Article  CAS  PubMed  Google Scholar 

Humbert, M. et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J. 61, 2200879 (2023).

Article  PubMed  Google Scholar 

Leber, L., Beaudet, A. & Muller, A. Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review. Pulm. Circ. 11, 2045894020977300 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Maron, B. A. & Galie, N. Diagnosis, treatment, and clinical management of pulmonary arterial hypertension in the contemporary era: a review. JAMA Cardiol. 1, 1056–1065 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Stevens, P. E., Levin, A. & Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann. Intern. Med. 158, 825–830 (2013).

Article  PubMed  Google Scholar 

Ronco, C., Bellasi, A. & Di Lullo, L. Cardiorenal syndrome: an overview. Adv. Chronic Kidney Dis. 25, 382–390 (2018).

Article  PubMed  Google Scholar 

Ronco, C., Haapio, M., House, A. A., Anavekar, N. & Bellomo, R. Cardiorenal syndrome. J. Am. Coll. Cardiol. 52, 1527–1539 (2008).

Article  PubMed  Google Scholar 

Hoeper, M. M. et al. A global view of pulmonary hypertension. Lancet Respir. Med. 4, 306–322 (2016).

Article  PubMed  Google Scholar 

GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709–733 (2020).

Article  Google Scholar 

Wang, L. et al. Prognostic effect of pulmonary hypertension in patients with chronic kidney disease: univariate and multivariate analyses of factors associated with survival. Front. Med. 9, 972937 (2022).

Article  Google Scholar 

Yang, Q. M. & Bao, X. R. Pulmonary hypertension in patients with stage 1–3 chronic kidney disease. Genet. Mol. Res. 13, 5695–5703 (2014).

Article  CAS  PubMed  Google Scholar 

Verbrugge, F. H., Guazzi, M., Testani, J. M. & Borlaug, B. A. Altered hemodynamics and end-organ damage in heart failure: impact on the lung and kidney. Circulation 142, 998–1012 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Bitker, L. et al. Presence of kidney disease as an outcome predictor in patients with pulmonary arterial hypertension. Am. J. Nephrol. 47, 134–143 (2018).

Article  PubMed  Google Scholar 

Nickel, N. P. et al. Kidney dysfunction in patients with pulmonary arterial hypertension. Pulm. Circ. 7, 38–54 (2017).

Article  CAS  PubMed